electroCore (ECOR) Current Deferred Revenue (2022 - 2026)
electroCore's (ECOR) quarterly Current Deferred Revenue came in at $62000.0 in Q1 2026, little changed year-on-year from $62000.0 in Q1 2025, and up 24.0% quarter-over-quarter from $50000.0 in Q4 2025.
electroCore (ECOR) Current Deferred Revenue (2022 - 2026) Analysis & Trends
electroCore's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $62000.0 for Q1 2026.
- On a quarterly basis, Current Deferred Revenue changed 0.0% year-over-year to $62000.0 in Q1 2026; TTM through Mar 2026 was $62000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $50000.0, down 35.9% from the prior year.
- Current Deferred Revenue rose to $62000.0 in Q1 2026 per ECOR's latest filing, from $50000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $245000.0 in Q4 2023 and bottomed at $17000.0 in Q1 2023.
- The 5-year median for Current Deferred Revenue is $68000.0 (2025), against an average of $92769.2.
- Biggest YoY gain for Current Deferred Revenue was 664.71% in 2024; the steepest drop was 76.67% in 2024.
- Year by year, Current Deferred Revenue stood at $152000.0 in 2022, then soared by 61.18% to $245000.0 in 2023, then slumped by 68.16% to $78000.0 in 2024, then slumped by 35.9% to $50000.0 in 2025, then increased by 24.0% to $62000.0 in 2026.
- Per Business Quant, the three latest ECOR Current Deferred Revenue figures stand at $62000.0 (Q1 2026), $50000.0 (Q4 2025), and $68000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 152,000.00 |